NDC 72606-036 – Omlyclo

Omalizumab 150 mg/mL · Injection · Subcutaneous

Human Prescription Drug

Product NDC72606-036

Product details

Brand name
Omlyclo
Generic name
omalizumab-igec
Labeler
CELLTRION USA, Inc.
Dosage form
Injection
Route
Subcutaneous
Marketing category
BLA · BLA761399
Marketed since
September 1, 2026
Listing expires
December 31, 2027
Pharmacologic class
Anti-IgE

Active ingredients

Uses, dosage, side effects and warnings for Omlyclo →

Package NDC codes (1)

Package NDCDescriptionSince
72606-036-011 SYRINGE, GLASS in 1 CARTON (72606-036-01) / 1 mL in 1 SYRINGE, GLASSSep 1, 2026

Other Omlyclo products